Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling
利用 RAF 和 MEK 抑制剂的变构特性来靶向治疗由致癌 BRAF 信号驱动的耐药性肿瘤
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-20-1351
Christos Adamopoulos #, Tamer A Ahmed #, Maxwell R Tucker #, Peter M U Ung, Min Xiao, Zoi Karoulia, Angelo Amabile, Xuewei Wu, Stuart A Aaronson, Celina Ang, Vito W Rebecca, Brian D Brown, Avner Schlessinger, Meenhard Herlyn, Qi Wang, David E Shaw, Poulikos I Poulikakos